SCHEMBL4004686

SCHEMBL4004686

C#Cc1ccc(C(=O)NC(C)(C)C(=O)Nc2ccc(N3CCN(C)CC3=O)c(C)c2)s1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 14/20 0.57
AR P10275 4/20 0.42
PDE7A Q13946 1/20 0.36
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008693 0.87 F10 (0.58) F10AR
SCHEMBL4463259 0.87 F10 (0.74) F10AR
SCHEMBL4473851 0.87 F10 (0.61) F10ARPDE7A
SCHEMBL5905038 0.86 F10 (0.57) F10ARHDAC8
SCHEMBL4003085 0.86 F10 (0.78) F10AR
SCHEMBL4008979 0.85 F10 (0.67) F10AR
SCHEMBL4005074 0.83 F10 (0.53) F10ARHDAC8
SCHEMBL4006744 0.83 F10 (0.57) F10ARHDAC8
SCHEMBL4006115 0.82 F10 (0.52) F10ARHDAC8
SCHEMBL4472368 0.82 F10 (0.59) F10AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563786-B2 Substituted thiophenecarboxamides, their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-07-21 US claimed
US-20060069082-A1 Novel substituted thiophenecarboxamides, their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069082-A1 Novel substituted thiophenecarboxamides, their preparation and their use as medicaments P2RY11, P2RX5, TPMT F10 2756/4885AR 442/4885PDE7A 2507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.